Cargando…
Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism
INTRODUCTION: Acute pulmonary embolism (APE) is a hazardous disorder with a high mortality. Combination of clinical, radiological, and serological parameters can improve risk stratification of APE. Most of the proposed combined scores were not validated in independent cohorts. Our aim was to validat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403935/ https://www.ncbi.nlm.nih.gov/pubmed/37543614 http://dx.doi.org/10.1186/s12931-023-02489-0 |
_version_ | 1785085184460193792 |
---|---|
author | Surov, Alexey Thormann, Maximilian Bär, Caroline Wienke, Andreas Borggrefe, Jan |
author_facet | Surov, Alexey Thormann, Maximilian Bär, Caroline Wienke, Andreas Borggrefe, Jan |
author_sort | Surov, Alexey |
collection | PubMed |
description | INTRODUCTION: Acute pulmonary embolism (APE) is a hazardous disorder with a high mortality. Combination of clinical, radiological, and serological parameters can improve risk stratification of APE. Most of the proposed combined scores were not validated in independent cohorts. Our aim was to validate the proposed clinical-radiological scores for prognosis of 7- and 30-day mortality in APE. MATERIALS AND METHODS: Our sample comprised 531 patients with APE, mean age 64.8 ± 15.6 years, 221 (41.6%) females and 310 (58.4%) males. The following parameters were collected: Age and sex of the patients, mortality within the observation time of 30 days, simplified pulmonary embolism severity index (sPESI), pH troponin level (pg/ml), minimal systolic and diastolic blood pressures (mmHg), heart rate, O(2) saturation, episodes of syncope, and need for vasopressors. On CT pulmonary angiography (CTPA), short axis ratio right ventricle/left ventricle (RV/LV), and reflux of contrast medium into the inferior vena cava were obtained. The following clinical-radiological scores were calculated: BOVA score, pulmonary embolism mortality score (PEMS), European Society of Cardiology (ESC) score, Kumamaru score, and Calgary acute pulmonary embolism (CAPE) score. RESULTS: Overall, 31 patients (5.8%) died within seven and 64 patients (12%) within 30 days. All scores showed high negative prognostic values ranging from 89.0 to 99.0%. PEMS and CAPE score demonstrated the highest specificity for 7-day mortality (93.4% and 85.0%), PEMS and BOVA for 30-day mortality (94.2% and 90.4%). The highest sensitivity was observed for ESC 2019 (96.8% and 95.3%). Kumamaru and CAPE scores had low sensitivity. All scores had low positive and high negative predictive values. CONCLUSION: For prognosis of 7- and 30-day mortality in APE, PEMS score has the highest specificity. ESC 2019 shows the highest sensitivity. All scores had low positive and high negative predictive values. |
format | Online Article Text |
id | pubmed-10403935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104039352023-08-06 Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism Surov, Alexey Thormann, Maximilian Bär, Caroline Wienke, Andreas Borggrefe, Jan Respir Res Research INTRODUCTION: Acute pulmonary embolism (APE) is a hazardous disorder with a high mortality. Combination of clinical, radiological, and serological parameters can improve risk stratification of APE. Most of the proposed combined scores were not validated in independent cohorts. Our aim was to validate the proposed clinical-radiological scores for prognosis of 7- and 30-day mortality in APE. MATERIALS AND METHODS: Our sample comprised 531 patients with APE, mean age 64.8 ± 15.6 years, 221 (41.6%) females and 310 (58.4%) males. The following parameters were collected: Age and sex of the patients, mortality within the observation time of 30 days, simplified pulmonary embolism severity index (sPESI), pH troponin level (pg/ml), minimal systolic and diastolic blood pressures (mmHg), heart rate, O(2) saturation, episodes of syncope, and need for vasopressors. On CT pulmonary angiography (CTPA), short axis ratio right ventricle/left ventricle (RV/LV), and reflux of contrast medium into the inferior vena cava were obtained. The following clinical-radiological scores were calculated: BOVA score, pulmonary embolism mortality score (PEMS), European Society of Cardiology (ESC) score, Kumamaru score, and Calgary acute pulmonary embolism (CAPE) score. RESULTS: Overall, 31 patients (5.8%) died within seven and 64 patients (12%) within 30 days. All scores showed high negative prognostic values ranging from 89.0 to 99.0%. PEMS and CAPE score demonstrated the highest specificity for 7-day mortality (93.4% and 85.0%), PEMS and BOVA for 30-day mortality (94.2% and 90.4%). The highest sensitivity was observed for ESC 2019 (96.8% and 95.3%). Kumamaru and CAPE scores had low sensitivity. All scores had low positive and high negative predictive values. CONCLUSION: For prognosis of 7- and 30-day mortality in APE, PEMS score has the highest specificity. ESC 2019 shows the highest sensitivity. All scores had low positive and high negative predictive values. BioMed Central 2023-08-05 2023 /pmc/articles/PMC10403935/ /pubmed/37543614 http://dx.doi.org/10.1186/s12931-023-02489-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Surov, Alexey Thormann, Maximilian Bär, Caroline Wienke, Andreas Borggrefe, Jan Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
title | Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
title_full | Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
title_fullStr | Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
title_full_unstemmed | Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
title_short | Validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
title_sort | validation of clinical-radiological scores for prognosis of mortality in acute pulmonary embolism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403935/ https://www.ncbi.nlm.nih.gov/pubmed/37543614 http://dx.doi.org/10.1186/s12931-023-02489-0 |
work_keys_str_mv | AT surovalexey validationofclinicalradiologicalscoresforprognosisofmortalityinacutepulmonaryembolism AT thormannmaximilian validationofclinicalradiologicalscoresforprognosisofmortalityinacutepulmonaryembolism AT barcaroline validationofclinicalradiologicalscoresforprognosisofmortalityinacutepulmonaryembolism AT wienkeandreas validationofclinicalradiologicalscoresforprognosisofmortalityinacutepulmonaryembolism AT borggrefejan validationofclinicalradiologicalscoresforprognosisofmortalityinacutepulmonaryembolism |